| Trial ID | NCT03909477 |
| Phase | N/A |
| Status | Recruiting |
| Condition | Cannabis Use |
| Intervention | Hyperpolarized Xenon-129 MRI of the lungs |
Cannabis smoking’s long-term pulmonary effects remain poorly characterized despite widespread use, creating a significant evidence gap for clinical counseling. This study employs advanced hyperpolarized xenon-129 MRI technology to provide unprecedented detailed imaging of lung function changes over time.
This is a 3-year longitudinal observational study examining pulmonary health impacts in cannabis smokers using hyperpolarized xenon-129 MRI, pulmonary function tests, CT imaging, and exercise capacity measurements. The study is currently recruiting participants and represents one of the first comprehensive investigations using this advanced MRI technique to track cannabis-related lung changes over time. Primary endpoints focus on detecting structural and functional pulmonary alterations that may not be captured by traditional imaging methods.
โIf this study demonstrates clinically meaningful pulmonary changes, it could fundamentally alter how I counsel patients about cannabis delivery methods and inform evidence-based harm reduction strategies. The xenon-129 MRI technology may reveal subtle lung changes that we’ve been unable to detect with conventional approaches.โ
๐ฌ Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan โ
Want to discuss this topic with other patients and caregivers? Join the forum discussion โ
Have thoughts on this? Share it:
This trial item was assembled from normalized source metadata and pipeline scoring.